Laddar...
Targeted anti-vascular therapies for ovarian cancer: current evidence
Ovarian cancer presents at advanced stage in around 75% of women, and despite improvements in treatments such as chemotherapy, the 5-year survival from the disease in women diagnosed between 1996 and 1999 in England and Wales was only 36%. Over 80% of patients with advanced ovarian cancer will relap...
Sparad:
| Huvudupphovsmän: | , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3566823/ https://ncbi.nlm.nih.gov/pubmed/23385789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.541 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|